34
Participants
Start Date
January 31, 2017
Primary Completion Date
February 28, 2026
Study Completion Date
May 31, 2026
Oral Ifetroban
Subjects will be treated with oral ifetroban or placebo daily for 365 days
Oral Placebo
Subjects will be treated with oral ifetroban or placebo daily for 365 days
Hospital for Special Surgery, New York
Thomas Jefferson University, Philadelphia
Johns Hopkins University, Baltimore
Medical University of South Carolina, Charleston
Cleveland Clinic - Florida, Weston
University of Nebraska Medical Center, Omaha
The Universtity of Arizona Arthrtis Center, Tucson
PGIMER, Chandigarh
KDH - Kokilaben Dhirubhai Ambani Hospital, Mumbai
B. J. Government Medical College, Pune
UCLA, Los Angeles
Massachusetts General Hospital, Boston
Baylor Research Institute, Dallas
Lead Sponsor
Cumberland Pharmaceuticals
INDUSTRY